Duffy Sean P. sold $510K of OMDA
Duffy Sean P. (Chief Executive Officer) sold 21,570 shares of Omada Health, Inc. (OMDA) at an average of $23.62 ($20.90–$24.81, $0.51M total) across 3 trades over 2026-08-07 to 2026-08-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new fact is the disclosed sale size, timing (Aug 7 to Aug 10), and post-transaction holdings (411,861 shares). There is no new company-specific fundamental information in the text.
Market read
Traders may treat this as a minor sentiment datapoint, but it is unlikely to drive a durable repricing without additional fundamental catalysts.
What to watch
The filing does not state reasons for the sale, and the price range ($20.90 to $24.81) spans multiple days, limiting inference about timing or valuation views.
Background
This is an SEC Form 4 insider transaction by Omada Health CEO Sean P. Duffy, reporting open-market sales under a Rule 10b5-1 plan.
Ticker impact
Omada Health CEO Sean P. Duffy sold about $509.6K of OMDA shares via an open-market sale under a pre-arranged 10b5-1 plan.
Likely limited, with any impact more sentiment-driven than fundamental.
Form 4 shows a planned sale (10b5-1) with no accompanying guidance, deal, or regulatory event; insider selling can still be read as signal, but the pre-arranged nature reduces interpretive weight.
Market effects
No direct sector read-through beyond routine insider activity in digital health.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, the market may overreact; the disclosure may not reflect new negative information.
Key entities
- issuerOmada Health, Inc.
Subject of the Form 4 insider transaction; CEO Sean P. Duffy sold shares totaling about $509.6K.
- insiderSean P. Duffy
CEO and officer/director who executed the open-market sales under a pre-arranged 10b5-1 plan.
